Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN185400 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN185400, RRID:AB_10780248
- Product name
- anti-Programmed Cell Death 1 (PDCD1) (Internal Region) antibody
- Antibody type
- Polyclonal
- Description
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Reactivity
- Human
- Host
- Goat
- Epitope
- Internal Region
- Vial size
- 100 μg
- Storage
- Aliquot and store at -20°C.
- Handling
- Minimize freezing and thawing.
Submitted references A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients.
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.
Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies.
Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects.
Nielsen C, Laustrup H, Voss A, Junker P, Husby S, Lillevang ST
Lupus 2004;13(7):510-6
Lupus 2004;13(7):510-6
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.
Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, Qiu Y, Jussif JM, Carter LL, Wood CR, Chaudhary D
FEBS letters 2004 Sep 10;574(1-3):37-41
FEBS letters 2004 Sep 10;574(1-3):37-41
Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies.
Sanghera DK, Manzi S, Bontempo F, Nestlerode C, Kamboh MI
Human genetics 2004 Oct;115(5):393-8
Human genetics 2004 Oct;115(5):393-8
Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects.
Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, Liz M, Martin J, Ordi J, Vicario JL, Gonzalez A
Arthritis and rheumatism 2004 Aug;50(8):2590-7
Arthritis and rheumatism 2004 Aug;50(8):2590-7
No comments: Submit comment
No validations: Submit validation data